Several meningioma tumor suppressors on chromosome 22 have been proposed, including SMARCB1, CHEK2, and CLH22. 40, 41CHEK2 halts cell-cycle progression in the presence of DNA damage, so loss of CHEK2 would likely be associated with increased genomic disruption. This evidence concerns the gene CHEK2 and meningioma.